XWELL Inc. Cash Flow Conversion Efficiency

Latest as of March 2026: 0.003x

XWELL Inc. cash flow conversion efficiency. Based on the latest financial reports, XWELL Inc. (XWEL) has a cash flow conversion efficiency ratio of 0.003x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-42.00K) by net assets ($-12.58 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of XWELL Inc. (2008–2025)

Cash flow conversion efficiency of XWELL Inc. from 2008 to 2025. This chart illustrates how XWELL Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View XWEL share price today for real-time trading data and today's change.

XWELL Inc. Cash Flow Conversion Ratio Explained

XWELL Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

XWELL Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of XWELL Inc. ranked by their cash flow conversion efficiency. Also see XWEL market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Myseum, Inc.
NASDAQ:MYSE
-0.159x
Polar Capital Global Healthcare Trust plc
LSE:PCGH
-0.003x
Media Lab SpA
PA:MLLAB
N/A
E Investment & Development
KO:093230
-0.020x
Westbond Enterprises Corp
V:WBE
0.025x
Starhedge SA
WAR:SHG
-0.004x
ASN Broker Public Company Limited
BK:ASN
0.027x
Bullfrog AI Holdings, Inc. Common Stock
NASDAQ:BFRG
-0.570x

Annual Cash Flow Conversion Efficiency for XWELL Inc. (2008–2025)

The table below shows the annual cash flow conversion efficiency of XWELL Inc. from 2008 to 2025. Review XWEL FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $-12.58 Million $-8.71 Million 0.693x +148.72%
2024-12-31 $7.74 Million $-11.01 Million -1.421x -85.45%
2023-12-31 $20.97 Million $-16.07 Million -0.766x -51.94%
2022-12-31 $47.95 Million $-24.19 Million -0.504x -422.29%
2021-12-31 $99.94 Million $15.64 Million 0.157x +150.30%
2020-12-31 $80.37 Million $-25.01 Million -0.311x -798.43%
2019-12-31 $-2.54 Million $-113.00K 0.045x +108.91%
2018-12-31 $13.13 Million $-6.57 Million -0.500x -88.25%
2017-12-31 $45.84 Million $-12.17 Million -0.266x -101.86%
2016-12-31 $64.17 Million $-8.44 Million -0.132x -107.30%
2015-12-31 $40.52 Million $-2.57 Million -0.063x +93.03%
2014-12-31 $31.18 Million $-28.38 Million -0.910x -343.33%
2013-12-31 $114.28 Million $-23.46 Million -0.205x -110.51%
2012-12-31 $148.33 Million $-14.47 Million -0.098x -102.11%
2011-12-31 $-1.17 Million $-5.38 Million 4.618x -82.65%
2010-12-31 $-239.00K $-6.36 Million 26.615x +8887.66%
2009-12-31 $-16.38 Million $-4.85 Million 0.296x -55.48%
2008-12-31 $-10.97 Million $-7.30 Million 0.665x --

About XWELL Inc.

NASDAQ:XWEL USA Diagnostics & Research
Market Cap
$5.67 Million
Market Cap Rank
#28253 Global
#5815 in USA
Share Price
$0.72
Change (1 day)
+3.68%
52-Week Range
$0.29 - $1.70
All Time High
$4680.00
About

XWELL, Inc. provides health and wellness services to travelers in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment provides traveler's spa services, including massage, and nail and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests to airport empl… Read more